ArticleCardiovascular research2017

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.

Justus Nonhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.